- Home
- ALEC vs SBI Comparison
ALEC vs SBI Comparison
Compare ALEC & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- SBI
- Stock Information
- Founded
- ALEC 2013
- SBI 1992
- Country
- ALEC United States
- SBI United States
- Employees
- ALEC N/A
- SBI N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- SBI Finance/Investors Services
- Sector
- ALEC Health Care
- SBI Finance
- Exchange
- ALEC Nasdaq
- SBI Nasdaq
- Market Cap
- ALEC 124.0M
- SBI 111.4M
- IPO Year
- ALEC 2019
- SBI N/A
- Fundamental
- Price
- ALEC $3.20
- SBI $7.96
- Analyst Decision
- ALEC Buy
- SBI
- Analyst Count
- ALEC 7
- SBI 0
- Target Price
- ALEC $4.50
- SBI N/A
- AVG Volume (30 Days)
- ALEC 1.3M
- SBI 39.5K
- Earning Date
- ALEC 11-05-2025
- SBI 01-01-0001
- Dividend Yield
- ALEC N/A
- SBI 4.52%
- EPS Growth
- ALEC N/A
- SBI N/A
- EPS
- ALEC N/A
- SBI N/A
- Revenue
- ALEC $81,130,000.00
- SBI N/A
- Revenue This Year
- ALEC N/A
- SBI N/A
- Revenue Next Year
- ALEC $290.50
- SBI N/A
- P/E Ratio
- ALEC N/A
- SBI N/A
- Revenue Growth
- ALEC 46.77
- SBI N/A
- 52 Week Low
- ALEC $0.87
- SBI $6.96
- 52 Week High
- ALEC $6.14
- SBI $8.00
- Technical
- Relative Strength Index (RSI)
- ALEC 57.52
- SBI 64.22
- Support Level
- ALEC $3.04
- SBI $7.86
- Resistance Level
- ALEC $3.33
- SBI $7.99
- Average True Range (ATR)
- ALEC 0.20
- SBI 0.06
- MACD
- ALEC -0.03
- SBI -0.00
- Stochastic Oscillator
- ALEC 63.00
- SBI 86.17
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About SBI Western Asset Intermediate Muni Fund Inc
Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.